- Home
- BMRN vs GLPI Comparison
BMRN vs GLPI Comparison
Compare BMRN & GLPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- GLPI
- Stock Information
- Founded
- BMRN 1996
- GLPI 2013
- Country
- BMRN United States
- GLPI United States
- Employees
- BMRN N/A
- GLPI N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- GLPI Real Estate Investment Trusts
- Sector
- BMRN Health Care
- GLPI Real Estate
- Exchange
- BMRN Nasdaq
- GLPI Nasdaq
- Market Cap
- BMRN 13.7B
- GLPI 13.1B
- IPO Year
- BMRN 1999
- GLPI N/A
- Fundamental
- Price
- BMRN $71.44
- GLPI $50.40
- Analyst Decision
- BMRN Buy
- GLPI Buy
- Analyst Count
- BMRN 22
- GLPI 17
- Target Price
- BMRN $94.00
- GLPI $53.32
- AVG Volume (30 Days)
- BMRN 1.5M
- GLPI 1.3M
- Earning Date
- BMRN 04-23-2025
- GLPI 04-24-2025
- Dividend Yield
- BMRN N/A
- GLPI 6.03%
- EPS Growth
- BMRN 153.71
- GLPI 3.52
- EPS
- BMRN 2.21
- GLPI 2.87
- Revenue
- BMRN $2,853,915,000.00
- GLPI $1,531,546,000.00
- Revenue This Year
- BMRN $12.23
- GLPI $6.49
- Revenue Next Year
- BMRN $9.90
- GLPI $3.07
- P/E Ratio
- BMRN $32.37
- GLPI $17.57
- Revenue Growth
- BMRN 17.97
- GLPI 6.33
- 52 Week Low
- BMRN $60.63
- GLPI $41.80
- 52 Week High
- BMRN $94.85
- GLPI $52.60
- Technical
- Relative Strength Index (RSI)
- BMRN 55.89
- GLPI 52.44
- Support Level
- BMRN $69.60
- GLPI $50.25
- Resistance Level
- BMRN $73.18
- GLPI $51.33
- Average True Range (ATR)
- BMRN 1.64
- GLPI 0.84
- MACD
- BMRN -0.15
- GLPI -0.04
- Stochastic Oscillator
- BMRN 63.45
- GLPI 64.49
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a real estate investment property trust whose primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The GLPI's portfolio consisted of interests in sixty one gaming and related facilities, the real property associated with thirty four gaming and related facilities operated by PENN, the real property associated with six gaming and related facilities operated by Caesars Entertainment Corporation.